BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 969 filers reported holding BAXTER INTL INC in Q3 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $672,000 | +4.3% | 10,717 | +0.7% | 0.07% | +1.5% |
| Q2 2017 | $644,000 | +0.6% | 10,638 | -13.8% | 0.06% | -3.0% |
| Q1 2017 | $640,000 | +8.1% | 12,346 | -7.5% | 0.07% | +1.5% |
| Q4 2016 | $592,000 | -6.8% | 13,346 | 0.0% | 0.07% | -4.3% |
| Q3 2016 | $635,000 | +7.1% | 13,346 | +1.8% | 0.07% | +4.5% |
| Q2 2016 | $593,000 | +5.7% | 13,105 | -4.0% | 0.07% | -1.5% |
| Q1 2016 | $561,000 | +7.7% | 13,645 | 0.0% | 0.07% | +4.7% |
| Q4 2015 | $521,000 | +15.0% | 13,645 | -1.0% | 0.06% | +10.3% |
| Q3 2015 | $453,000 | -61.1% | 13,785 | -17.3% | 0.06% | -55.7% |
| Q2 2015 | $1,165,000 | +4.8% | 16,666 | +2.7% | 0.13% | +10.1% |
| Q1 2015 | $1,112,000 | -15.4% | 16,235 | -9.4% | 0.12% | -16.8% |
| Q4 2014 | $1,314,000 | +3.1% | 17,925 | +0.9% | 0.14% | +4.4% |
| Q3 2014 | $1,275,000 | +3.2% | 17,762 | +3.9% | 0.14% | +7.0% |
| Q2 2014 | $1,236,000 | -4.7% | 17,090 | -3.0% | 0.13% | -9.2% |
| Q1 2014 | $1,297,000 | +3.3% | 17,625 | -2.4% | 0.14% | +2.2% |
| Q4 2013 | $1,256,000 | +5.0% | 18,053 | -0.8% | 0.14% | -1.4% |
| Q3 2013 | $1,196,000 | -5.7% | 18,204 | -0.5% | 0.14% | -9.1% |
| Q2 2013 | $1,268,000 | – | 18,304 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
| SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
| Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
| Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
| HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
| Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
| 13D Management LLC | 200,318 | $14,791,000 | 3.77% |
| ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
| Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |